# Arbutus Biopharma Corp: Form 8-K, filed Jul 16, 2015

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 8-K
- Filed: 2015-07-16
- Accepted by EDGAR: Jul 16, 2015, 17:26 ET
- Period: 2015-07-11
- Accession: 0000912282-15-000243
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000091228215000243/tekmira8k_071615.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000091228215000243/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000091228215000243/tekmira8k_071615.htm

Filed Jul 16, 2015.
Source: SEC EDGAR, the filing index for accession 0000912282-15-000243. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.
